Literature DB >> 22215815

Evaluation of salivary anti-Salmonella typhi lipopolysaccharide IgA ELISA for serodiagnosis of typhoid fever in children.

Zeeba Zaka-ur-Rab1, Shaad Abqari, Tabassum Shahab, Najmul Islam, Indu Shukla.   

Abstract

This observational study was conducted to determine the diagnostic accuracy of ELISA for the detection of anti-Salmonella typhi lipopolysaccharide (LPS) salivary immunoglobulin A (IgA) antibodies in 37 children with culture confirmed typhoid, 30 febrile controls with an alternative diagnosis and 30 healthy controls. The test was positive in 33/37 (89.2%) cases of typhoid, but negative in all patients in the two control groups. Maximum absorbance of anti-LPS IgA was observed during the second and third weeks of typhoid, with a progressive decline thereafter. The sensitivity of ELISA was 71.4%, 100%, 100%, 9.1% and 0%, in first, second, third, fourth and fifth week of illness, respectively. Further large scale studies measuring salivary anti-LPS IgA antibodies are needed to confirm the potential of saliva-based serology in children with suspected typhoid.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215815     DOI: 10.1136/adc.2011.300622

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Detection of Salivary IgA Antibodies Against the HlyE Antigen as a Diagnosis of Typhoid Fever.

Authors:  Kai Ling Chin; Nur Eliyana Mohd Redhuan; Prabha Balaram; Kia Kien Phua; Eugene Boon Beng Ong
Journal:  J Clin Diagn Res       Date:  2016-06-01

3.  Salivary Anti-50 kDa Antibodies as a Useful Biomarker for Diagnosis of Typhoid Fever.

Authors:  Nur Eliyana Mohd Redhuan; Kai Ling Chin; Azreen Syazril Adnan; Asma Ismail; Prabha Balaram; Kia Kien Phua
Journal:  J Clin Diagn Res       Date:  2017-06-01

4.  Serodiagnosis of Acute Typhoid Fever in Nigerian Pediatric Cases by Detection of Serum IgA and IgG Against Hemolysin E and Lipopolysaccharide.

Authors:  D Huw Davies; Aarti Jain; Rie Nakajima; Li Liang; Algis Jasinskis; Medalyn Supnet; Philip L Felgner; Andy Teng; Jozelyn Pablo; Douglas M Molina; Stephen K Obaro
Journal:  Am J Trop Med Hyg       Date:  2016-05-23       Impact factor: 2.345

Review 5.  Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever.

Authors:  Lalith Wijedoru; Sue Mallett; Christopher M Parry
Journal:  Cochrane Database Syst Rev       Date:  2017-05-26

6.  Why the development of effective typhoid control measures requires the use of human challenge studies.

Authors:  Claire Jones; Thomas C Darton; Andrew J Pollard
Journal:  Front Microbiol       Date:  2014-12-16       Impact factor: 5.640

Review 7.  Salivary biomarker development using genomic, proteomic and metabolomic approaches.

Authors:  Nicolai J Bonne; David Tw Wong
Journal:  Genome Med       Date:  2012-10-30       Impact factor: 11.117

8.  Evaluation of sensitivity and specificity of ELISA against Widal test for typhoid diagnosis in endemic population of Kathmandu.

Authors:  Anurag Adhikari; Ramanuj Rauniyar; Pramod Prasad Raut; Krishna Das Manandhar; Birendra Prasad Gupta
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

Review 9.  Control of Invasive Salmonella Disease in Africa: Is There a Role for Human Challenge Models?

Authors:  Malick M Gibani; Celina Jin; Thomas C Darton; Andrew J Pollard
Journal:  Clin Infect Dis       Date:  2015-11-01       Impact factor: 9.079

10.  A Meta-Analysis of Typhoid Diagnostic Accuracy Studies: A Recommendation to Adopt a Standardized Composite Reference.

Authors:  Helen L Storey; Ying Huang; Chris Crudder; Allison Golden; Tala de los Santos; Kenneth Hawkins
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.